A team of MIT researchers, backed by collaborators across the U.S. and in the U.K., identifies a biomarker in fragile X syndrome, the most common inherited autism form. Mice modeling the autism spectrum disorder exhibit the same pattern of differences in low-frequency waves as human patients, a finding that could advance treatment studies.